Integrated Analysis of Multidimensional Genomic Data on CALGB 40601 (Alliance), a Randomized Neoadjuvant Phase III Trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-Positive Breast Cancer
- Citation:
- Cancer Res vol 77 (4 suppl) Abstract nr S3-05
- Meeting Instance:
- SABCS 2016
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Program:
- TRP
- Primary Committee:
- Sequencing
- Sec. Committees:
- Breast
- Pharmas:
- Grants:
- U10CA031946, U10CA033601, U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Maki Tanioka Chen Fan Lisa A. Carey Terry Hyslop Brandelyn Pitcher Joel S. Parker Katie Hoadley N. Lynn Henry Sara Tolaney Chau Dang Ian E. Krop Lyndsay Harris Donald A. Berry Elaine Mardis Charles M. Perou Eric P Winer Clifford A Hudis
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-UT003
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: